» Articles » PMID: 35212622

Signature-scoring Methods Developed for Bulk Samples Are Not Adequate for Cancer Single-cell RNA Sequencing Data

Overview
Journal Elife
Specialty Biology
Date 2022 Feb 25
PMID 35212622
Authors
Affiliations
Soon will be listed here.
Abstract

Quantifying the activity of gene expression signatures is common in analyses of single-cell RNA sequencing data. Methods originally developed for bulk samples are often used for this purpose without accounting for contextual differences between bulk and single-cell data. More broadly, few attempts have been made to benchmark these methods. Here, we benchmark five such methods, including single sample gene set enrichment analysis (ssGSEA), Gene Set Variation Analysis (GSVA), AUCell, Single Cell Signature Explorer (SCSE), and a new method we developed, Jointly Assessing Signature Mean and Inferring Enrichment (JASMINE). Using cancer as an example, we show cancer cells consistently express more genes than normal cells. This imbalance leads to bias in performance by bulk-sample-based ssGSEA in gold standard tests and down sampling experiments. In contrast, single-cell-based methods are less susceptible. Our results suggest caution should be exercised when using bulk-sample-based methods in single-cell data analyses, and cellular contexts should be taken into consideration when designing benchmarking strategies.

Citing Articles

Polyploid cancer cells reveal signatures of chemotherapy resistance.

Schmidt M, Naghdloo A, Prabakar R, Kamal M, Cadaneanu R, Garraway I Oncogene. 2024; 44(7):439-449.

PMID: 39578659 PMC: 11810791. DOI: 10.1038/s41388-024-03212-z.


Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms.

Shivarov V, Tsvetkova G, Micheva I, Hadjiev E, Petrova J, Ivanova A Front Immunol. 2024; 15:1427810.

PMID: 39351227 PMC: 11439724. DOI: 10.3389/fimmu.2024.1427810.


Comparative analysis of single-cell pathway scoring methods and a novel approach.

Wang R, Thakar J NAR Genom Bioinform. 2024; 6(3):lqae124.

PMID: 39318507 PMC: 11420841. DOI: 10.1093/nargab/lqae124.


Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Jagodinsky J, Vera J, Jin W, Shea A, Clark P, Sriramaneni R Sci Transl Med. 2024; 16(765):eadk0642.

PMID: 39292804 PMC: 11522033. DOI: 10.1126/scitranslmed.adk0642.


Innovative aspects and applications of single cell technology for different diseases.

Ali A, Manzoor S, Ali T, Asim M, Muhammad G, Ahmad A Am J Cancer Res. 2024; 14(8):4028-4048.

PMID: 39267684 PMC: 11387862. DOI: 10.62347/VUFU1836.


References
1.
Noureen N, Ye Z, Chen Y, Wang X, Zheng S . Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data. Elife. 2022; 11. PMC: 8916770. DOI: 10.7554/eLife.71994. View

2.
Pont F, Tosolini M, Fournie J . Single-Cell Signature Explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets. Nucleic Acids Res. 2019; 47(21):e133. PMC: 6868346. DOI: 10.1093/nar/gkz601. View

3.
Venteicher A, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin M . Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 2017; 355(6332). PMC: 5519096. DOI: 10.1126/science.aai8478. View

4.
Bi K, He M, Bakouny Z, Kanodia A, Napolitano S, Wu J . Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021; 39(5):649-661.e5. PMC: 8115394. DOI: 10.1016/j.ccell.2021.02.015. View

5.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View